CEMIP and cancer: Evidence showed that overexpressed CASC19 elevated the expressions of CEMIP and EMT biomarkers in CRC cells, which can be reversed by inducing the expression of miR-140-5p in cells [46]; they were highly correlated with the poor cancer prognosis [47].